Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality-Reference-Cited by-同舟云学术

Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality

Published:2018-08 Issue:8 Volume:30 Page:959-966
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Mendes Leandro C.,Ferreira Paulo A.,Miotto Noelle,Zanaga Letícia,Lazarini Maria S.,Gonçales Eduardo S.L.,Pedro Marcelo N.,Gonçales Fernando L.,Stucchi Raquel S.B.,Vigani Aline G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008;Younossi;Clin Gastroenterol Hepatol,2011

2. Steatosis in chronic hepatitis C: why does it really matter?;Asselah;Gut,2006

3. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection;Cross;J Viral Hepat,2009

4. A systematic review of the quality of liver biopsy specimens;Cholongitas;Am J Clin Pathol,2006

5. Intermediate fibrosis staging in hepatitis C: a problem not overcome by optimal samples or pathologists’ expertise;Chindamo;Ann Hepatol,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

2. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease;Radiology;2022-01

3. Improved Ultrasound Attenuation Measurement Method for the Non-invasive Evaluation of Hepatic Steatosis Using FibroScan;Ultrasound in Medicine & Biology;2021-11

4. Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease;Alimentary Pharmacology & Therapeutics;2020-09-27

5. Novel reliability criteria for controlled attenuation parameter assessments for non‐invasive evaluation of hepatic steatosis;United European Gastroenterology Journal;2020-04